News

Arcinova has now been rebranded to Quotient Sciences

Quotient Sciences, the drug development and manufacturing accelerator, announces that it has completed the rebrand of Arcinova, the Alnwick U.K.-based contract development and manufacturing organization (CDMO). Now called Quotient Sciences - Alnwick, the site has significant expertise in drug substance manufacture, isotope labelling, bioanalysis and drug product development, playing a key role in strengthening Quotient’s services portfolio from candidate selection to commercial manufacturing.

Bioanalysis Zone Article: Integrating bioanalysis with clinical studies and pharmacokinetics: an interview with Stuart McDougall

In this interview Stuart McDougall, Head of Bioanalytical Services at Quotient Sciences- Alnwick (Northumberland, UK), discusses the technologies used to generate fast, reliable data for drug development and how recently Arcinova has been acquired by Quotient Sciences. He explains what this new partnership means and how Arcinova/Quotient are preparing to address the needs of the future.

Quotient featured in Drug Development & Delivery's Outsourcing Formulation Development & Manufacturing Special Feature

Quotient's VP of Drug Development Sciences, Dr Sarah Stevens, discusses our recent acquisition of Arcinova and the integration of drug substance, drug product, and clinical testing capabilities – all under one organization, in Drug Development & Delivery's Special Feature Report

Quotient's CEO featured in 2021 edition of U.S. Pharma and Biopharma Report

An interview with Quotient's CEO, Mark Egerton, was featured in the latest 2021 edition of the U.S Pharma and Biopharma Report by Global Business Reports.

Quotient Sciences wins multiple categories in 2021 CRO Leadership Awards

Content: Quotient has been recognized with multiple 2021 CRO Leadership Awards, including two Champion Awards. The CRO Leadership Awards recognizes top performing outsourcing organizations in the drug development arena. Quotient received leadership awards in five of the overall six categories.

Quotient featured in Drug Development & Delivery's Solubility Special Feature Report

Quotient Sciences was featured in Drug Development & Delivery's Special Feature article entitled: "Improving Bioavailability & Solubility: Each Molecule Is Unique."

Quotient Sciences Acquires Arcinova, the UK-Based Contract Development and Manufacturing Organization

Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide.

Drug Substance Formulation Development Clinical Trial Manufacturing Commercial Manufacturing Clinical Pharmacology Bioanalysis Data Sciences Drug Development Consulting

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.